Covidien Financial Statements
Covidien Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | September |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Covidien Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 10,170.0 | 9,647.0 | 9,543.0 |
| Gross Profit ($ mil.) | 4,837.0 | 4,486.0 | -- |
| Operating Income ($ mil.) | 438.0 | 2,128.0 | -- |
| Total Net Income ($ mil.) | (342.0) | 1,155.0 | -- |
| Diluted EPS (Net Income) | (0.69) | -- | -- |
Covidien Stock Quote & Chart
07/08/08 15:03:23 EST •
NYSE •
48.00
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Covidien Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.33 | 2.04 | 1.54 |
| Price/Earnings Ratio | -- | 19.98 | 15.14 |
| Price/Book Ratio | 3.51 | 2.21 | 1.46 |
| Price/Cash Flow Ratio | 10.72 | 15.10 | 9.41 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Covidien Financial Ratios
Covidien Competitive Intelligence
| BD | Bard | Johnson & Johnson | |
|---|---|---|---|
| Annual Sales ($ mil.) | 6,359.7 | 2,202.0 | 61,095.0 |
| Employees | -- | 10,200 | -- |
| Market Cap ($ mil.) | 19,564.3 | 8,657.0 | 182,285.9 |
Competitive Landscape
